Skip to main content
Premium Trial:

Request an Annual Quote

Genetix, Varian, PerkinElmer, Bruker BioSciences

Premium

Genetix has launched Protein Array Platform, a system for printing protein, peptide, and antibody arrays. The system includes a QArraymini microarray spotter and aQu spotting pins, as well as a Protein Array Spotting solution and epoxy coated slides. The spotted slides are processed using a Protein Array Processing Kit that removes unbound proteins and blocks non-specific binding. The slide is scanned and data analyzed on the aQuire confocal laser scanner.


Varian has introduced MS Workstation 6.3 with CFR Part 11 tools that allow customers using Varian’s 1200L LC/MS system to comply with FDA’s QC regulations on access control, audit trails, and validation. Customers can document their activities with electronic signatures and record keeping.


At ABRF this week, PerkinElmer released its Proxpress 2D Proteomic Imaging System, which features a new, high-speed CCD-based imaging camera for increased speed, sensitivity, and resolution, according to the company. The Proxpress incorporates PE’s ProScan image acquisition software for automated spot acquisition and its ProFinger 2D gel analysis software.


Bruker BioSciences announced this week that it will release a new Proteomics Research Information Management System at Pittcon next week. The software will combine and integrate data from its mass spec and X-ray crystallography platforms. Access will also be provided to NMR data.

 

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.